PerkinElmer Inc (PKI): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

PerkinElmer ( PKI) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, PerkinElmer rose $0.58 (1.6%) to $37.50 on average volume. Throughout the day, 1,587,976 shares of PerkinElmer exchanged hands as compared to its average daily volume of 1,071,300 shares. The stock ranged in a price between $36.59-$37.69 after having opened the day at $36.84 as compared to the previous trading day's close of $36.92. Other companies within the Health Services industry that increased today were: Response Genetics ( RGDX), up 14.5%, Cardica ( CRDC), up 10.5%, TearLab Corpoartion ( TEAR), up 8.8% and Arrhythmia Research Technology ( HRT), up 6.5%.

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. PerkinElmer has a market cap of $4.1 billion and is part of the health care sector. Shares are up 16.3% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate PerkinElmer a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates PerkinElmer as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, BG Medicine ( BGMD), down 11.3%, ZELTIQ Aesthetics ( ZLTQ), down 6.4%, Misonix ( MSON), down 6.4% and Pingtan Marine Enterprise ( PME), down 6.2% , were all laggards within the health services industry with ResMed ( RMD) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Takes Cautious Approach to M&A

PerkinElmer Medical Imaging Unit Sale Could Be in the Works

Trade-Ideas: PerkinElmer (PKI) Is Today's "Barbarian At The Gate" Stock

Jim Cramer's 'Mad Money' Recap: Short-Term Pain? Try Investing for Long-Term Gain